What is the role of dialysis in patients with severe lithium toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Dialysis in Severe Lithium Toxicity

Hemodialysis is the treatment of choice for severe lithium intoxication, particularly when serum lithium levels are ≥3.5 mEq/L with significant symptoms, or at any level with severe neurological or cardiovascular compromise. 1

Indications for Hemodialysis

The American Heart Association recommends hemodialysis urgently in the following situations 1:

  • Serum lithium ≥3.5 mEq/L with significant symptoms (neurological or cardiovascular) 1
  • Any lithium level with severe cardiovascular compromise, including symptomatic bradycardia, advanced AV block, or refractory hypotension 1
  • Refractory toxicity despite conservative management 1

The FDA drug label confirms hemodialysis as "an effective and rapid means of removing the ion from the severely toxic patient." 2

Acute vs. Chronic Toxicity: Critical Distinction

Patients with chronic or acute-on-chronic toxicity require more aggressive dialysis intervention than those with acute overdose alone. 3, 4

  • Acute intoxication (overdose in lithium-naive patients): Often presents with milder symptoms despite potentially lethal levels (>3.5 mEq/L), as lithium has not yet distributed into tissues 3

    • In one series, 10 patients with acute toxicity and levels ≥3.5 mEq/L had mild symptoms; 5 received hemodialysis and 5 did not—none died or had permanent sequelae 3
  • Chronic toxicity (during maintenance therapy): Associated with prolonged tissue exposure, greater intracellular accumulation, and more severe neurological/cardiovascular symptoms at lower serum levels 3, 4

    • These patients should receive hemodialysis if serum lithium >2.5 mmol/L with clinical features 4

Hemodialysis Protocol

Duration and monitoring are critical to prevent rebound toxicity: 1

  • Continue hemodialysis until lithium level <1.0 mEq/L is achieved after redistribution 1
  • Typical duration: 6-8 hours 1
  • Measure lithium level 4-6 hours post-dialysis to evaluate for rebound, as lithium redistributes from intracellular compartments 1
  • Mean lithium clearance with hemodialysis: 173 ml/min 5

Rebound Phenomenon and Extended Dialysis Strategies

Serum lithium frequently rebounds after standard hemodialysis due to redistribution from tissues, often requiring repeated treatments. 6, 4

To address this limitation:

  • Hemodialysis followed by continuous venovenous hemodiafiltration (CVVHDF) effectively prevents rebound by continuing lithium removal during the redistribution phase 5

    • CVVHDF clearance: 61 ml/min (lower than HD but sustained) 5
    • This combined approach is most effective for removing intracellular lithium 5
  • Prolonged hemodialysis (>16 hours) or continuous arteriovenous/venovenous hemodiafiltration allows effective total body lithium removal and avoids rebound 4

Alternative Dialysis Modalities

Peritoneal dialysis is less effective than hemodialysis but can be used when hemodialysis is unavailable: 7, 6

  • Peritoneal dialysis lowers lithium levels more slowly than hemodialysis 7, 6
  • Should only be considered if hemodialysis facilities are not accessible 6

Conservative Management for Mild-Moderate Toxicity

For patients who do not meet criteria for dialysis 2, 7:

  • Cessation or reduction of lithium dosage 2, 7
  • Gastric lavage if recent ingestion 2, 7
  • Correction of fluid and electrolyte imbalance 2
  • Maintenance of high-normal sodium levels to promote lithium excretion 7
  • Regulation of kidney function 2

Critical Pitfalls to Avoid

Do not rely solely on serum lithium levels to guide dialysis decisions in chronic toxicity—clinical symptoms (especially neurological) are more important, as tissue levels may be significantly elevated despite moderate serum concentrations 3, 4

Permanent neurological sequelae can occur despite effective hemodialysis if treatment is delayed—prolonged exposure to toxic tissue levels causes irreversible basal ganglia and cerebellar damage 6

Single hemodialysis sessions may be insufficient—always check post-dialysis levels after redistribution period to identify rebound requiring additional treatment 1, 4

References

Guideline

Treatment of Lithium Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lithium intoxication: clinical course and therapeutic considerations.

Mineral and electrolyte metabolism, 1988

Research

Management of lithium toxicity.

Toxicological reviews, 2006

Research

Treatment of acute lithium toxicity.

Veterinary and human toxicology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.